epocrates logo
epocrates logo
epocrates logo
  • Home
  • Search
  • Tools
  • Saved
  • 0
    Notifications
  • CME
  • Help & Feedback
  • About Us
  • Business Solutions

The clinical information you need, at your fingertips.

Medical News for You

Journal Article Synopsis

Hepatology

2h

Treat hepatitis D earlier? New AASLD guidance expands screening and antiviral use

Expert opinion recommends universal HDV testing in hepatitis B and broader use of bulevirtide-based therapy. . .

Journal Article Synopsis

JAMA Netw Open

4h

Punch-incision technique boosts diabetic foot ulcer healing

A simple, low-cost wound-bed procedure nearly doubled ulcer closure rates in a randomized trial. . .

Internally Generated Content

AMA

5h

New AMA policy calls for deprescribing as part of routine care

Supervised medication changes and shared decisions can help align treatment with patients’ goals. . .
Journal Article Synopsis

Gallup

7h

Patients draw the line at AI decisions without clinician review

They know who should have the final say when AI plays a part in their care, but the answer is more nuanced than human versus machine. . .
Internally Generated Content

ACAAI 2026

8h

Why do clinicians still order food allergy panels?

Survey finds awareness of false positives does not always translate into appropriate testing. . .
Journal Article Synopsis

Ann Biomed Eng

10h

Concussion risk: Are we overlooking straight-line impacts?

New data challenge the long-held belief that rotational motion is the main driver of concussion. . .

Journal Article Synopsis

JACC Heart Fail

12h

Targeted EHR alerts nearly double prescribing of heart failure therapy

A tailored electronic prompt improved treatment uptake across three health systems without a detected increase in hyperkalemia. . .
Journal Article Synopsis

JAMA Netw Open

14h

Denosumab linked to fewer repeat fractures than bisphosphonates

An observational study found lower refracture risk over 3 years, particularly after an initial fracture outside the hip or spine. . .
Journal Article Synopsis

NEI Fall Congress 2026

1d

Lumateperone shows rapid benefit in bipolar mania

A second phase 3 trial supports a planned FDA submission, with symptom improvement evident by day 3. . .
Trending icon

TRENDING THIS WEEK

learn more about epocrates plus

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

About Us

Features

Business Solutions

Help & Feedback

Terms of Use

Privacy Policy

visit epocrates on instagram
visit epocrates on facebook
visit epocrates on youtube
visit epocrates on twitter
visit epocrates on linkedIn

© 2026 epocrates, Inc.

download epocrates on app storedownload epocrates on google play

Do not sell or share my personal information

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & FeedbackCookie Preferences
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information